LungLife AI Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Paul Pagano

Chief executive officer

US$316.6k

Total compensation

CEO salary percentage93.4%
CEO tenure5.1yrs
CEO ownership0.09%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has Paul Pagano's remuneration changed compared to LungLife AI's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$5m

Dec 31 2023US$317kUS$296k

-US$5m

Sep 30 2023n/an/a

-US$6m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$335kUS$275k

-US$8m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$356kUS$230k

-US$7m

Compensation vs Market: Paul's total compensation ($USD316.60K) is below average for companies of similar size in the German market ($USD492.37K).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.


CEO

Paul Pagano (39 yo)

5.1yrs

Tenure

US$316,595

Compensation

Dr. Paul Pagano, Ph.D. has been Chief Scientific Officer at LungLife AI, Inc. since October 2019. Dr. Pagano serves as Chief Executive Officer of LungLife AI, Inc and serves as Executive Director since Jul...